G1 Therapeutics ROA 2016-2024 | GTHX
Current and historical return on assets (ROA) values for G1 Therapeutics (GTHX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
ROA - Return on Assets Historical Data |
Date |
TTM Net Income |
Total Assets |
Return on Assets |
2024-06-30 |
$-0.04B |
$0.10B |
-38.60% |
2024-03-31 |
$-0.03B |
$0.10B |
-23.76% |
2023-12-31 |
$-0.05B |
$0.12B |
-33.98% |
2023-09-30 |
$-0.07B |
$0.13B |
-45.01% |
2023-06-30 |
$-0.08B |
$0.15B |
-46.92% |
2023-03-31 |
$-0.13B |
$0.16B |
-71.59% |
2022-12-31 |
$-0.15B |
$0.19B |
-77.37% |
2022-09-30 |
$-0.15B |
$0.17B |
-74.09% |
2022-06-30 |
$-0.17B |
$0.19B |
-75.39% |
2022-03-31 |
$-0.17B |
$0.22B |
-68.55% |
2021-12-31 |
$-0.15B |
$0.25B |
-54.29% |
2021-09-30 |
$-0.13B |
$0.24B |
-49.91% |
2021-06-30 |
$-0.10B |
$0.28B |
-38.02% |
2021-03-31 |
$-0.09B |
$0.31B |
-35.81% |
2020-12-31 |
$-0.10B |
$0.23B |
-39.68% |
2020-09-30 |
$-0.11B |
$0.26B |
-41.37% |
2020-06-30 |
$-0.13B |
$0.25B |
-46.36% |
2020-03-31 |
$-0.13B |
$0.26B |
-43.32% |
2019-12-31 |
$-0.12B |
$0.29B |
-37.95% |
2019-09-30 |
$-0.11B |
$0.32B |
-32.36% |
2019-06-30 |
$-0.10B |
$0.33B |
-27.35% |
2019-03-31 |
$-0.09B |
$0.35B |
-27.24% |
2018-12-31 |
$-0.09B |
$0.37B |
-29.54% |
2018-09-30 |
$-0.08B |
$0.39B |
-35.25% |
2018-06-30 |
$-0.07B |
$0.19B |
-48.37% |
2018-03-31 |
$-0.07B |
$0.20B |
-49.01% |
2017-12-31 |
$-0.07B |
$0.11B |
-72.42% |
2017-06-30 |
$-0.04B |
$0.13B |
-119.40% |
2017-03-31 |
$-0.03B |
$0.00B |
inf% |